Gilles Manceau Selected Research

Intraoperative Complications

10/2017

Outpatient Appendectomy in an Emergency Outpatient Surgery Unit 24 h a Day: An Intention-to-Treat Analysis of 194 Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gilles Manceau Research Topics

Disease

13	Neoplasms (Cancer) 02/2022 - 12/2009
9	Colorectal Neoplasms (Colorectal Cancer) 11/2022 - 12/2009
9	Colonic Neoplasms (Colon Cancer) 01/2022 - 12/2009
8	Rectal Neoplasms (Rectal Cancer) 01/2022 - 03/2012
5	Neoplasm Metastasis (Metastasis) 02/2022 - 09/2013
3	Adenocarcinoma 01/2022 - 12/2019
3	Anastomotic Leak 09/2019 - 01/2017
2	Fistula 02/2022 - 11/2021
2	Lymphatic Metastasis 01/2022 - 11/2018
2	Peritonitis 10/2018 - 10/2017
1	Microsatellite Instability 11/2022
1	Pulmonary Edema 01/2022
1	Hypertensive Crisis 01/2022
1	Cardiac Arrhythmias (Arrythmia) 01/2022
1	Ischemia 01/2022
1	Cardiomyopathies (Cardiomyopathy) 01/2022
1	Paraganglioma (Paragangliomas) 01/2022
1	Pheochromocytoma 01/2022
1	Atrial Fibrillation 11/2021
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 10/2021
1	Polyps 04/2021
1	Adenoma (Adenomas) 04/2021
1	Colonic Polyps 12/2019
1	Prolapse 01/2019
1	Colic (Abdominal Cramps) 11/2018
1	Infections 07/2018
1	Rupture 07/2018
1	Abscess 10/2017
1	Intraoperative Complications 10/2017
1	Appendicitis 10/2017
1	Ischemic Colitis 03/2012
1	Diverticular Diseases 03/2012
1	Carcinogenesis 03/2012

Drug/Important Bio-Agent (IBA)

3	Cetuximab (Erbitux)FDA Link 10/2016 - 12/2009
3	ErbB Receptors (EGF Receptor)IBA 01/2014 - 12/2009
2	AntibodiesIBA 10/2016 - 06/2014
2	MicroRNAs (MicroRNA)IBA 06/2014 - 03/2012
1	Tumor Biomarkers (Tumor Markers)IBA 11/2022
1	Contrast MediaIBA 02/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	CatecholaminesIBA 01/2022
1	4-toluenesulfonyl fluoride (TSF)IBA 11/2018
1	Formaldehyde (Formol)FDA Link 10/2016
1	Panitumumab (Vectibix)FDA Link 10/2016
1	ParaffinIBA 10/2016
1	Monoclonal AntibodiesIBA 01/2014
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2013
1	Pharmaceutical PreparationsIBA 03/2012
1	Biomarkers (Surrogate Marker)IBA 03/2012

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 02/2022 - 03/2012
6	Neoadjuvant Therapy 01/2022 - 01/2017
5	Adjuvant Chemotherapy 01/2022 - 10/2018
5	Colectomy 01/2022 - 03/2012
4	Therapeutics 02/2022 - 12/2009
3	Chemoradiotherapy 01/2022 - 09/2013
2	Laparotomy 12/2019 - 06/2019
2	Stents 03/2019 - 01/2019
1	Precision Medicine 11/2022
1	Oral Administration 02/2022
1	Perioperative Period 01/2022
1	Catheter Ablation 11/2021
1	Pancreaticoduodenectomy 10/2021
1	Operative Surgical Procedures 10/2021
1	Radiotherapy 06/2020
1	Immunotherapy 11/2019
1	Colonic Pouches (S Pouch) 01/2019
1	Ligation 07/2018
1	General Anesthesia 10/2017
1	Ambulatory Surgical Procedures (Outpatient Surgery) 10/2017
1	Length of Stay 01/2017
1	Proctectomy 02/2015